Allspring Global Investments Holdings, LLC Janux Therapeutics, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $53.9 Billion
- Q1 2025
A detailed history of Allspring Global Investments Holdings, LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 9,033 shares of JANX stock, worth $209,746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,033
Previous 5,865
54.02%
Holding current value
$209,746
Previous $314,000
22.61%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding JANX
# of Institutions
193Shares Held
57.3MCall Options Held
626KPut Options Held
155K-
Ra Capital Management, L.P. Boston, MA11.2MShares$260 Million6.27% of portfolio
-
Janus Henderson Group PLC London, X04.6MShares$107 Million0.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.65MShares$84.9 Million0.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.33MShares$77.3 Million4.61% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$54.4 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $967M
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...